Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city

International Braz J Urol

Volumn 33, Issue 1, 2007, Pages 42-48

  Kiffer, Carlos R V ^a   Mendes, Caio ^a   Oplustil, Carmen P ^a   Sampaio, Jorge L ^a  

^a Fleury   (Brazil)

Author keywords

Drug resistance; Drug therapy; Escherichia coli; Urinary tract infections

Indexed keywords

EID: 33947361129     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/s1677-55382007000100007     Document Type: Article

References (19)

1. Gupta K, Hooton TM, Stamm WE: Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001; 135: 41-50.
2. Zhanel GG, Karlowsky JA, Harding GK, Carrie A, Mazzulli T, Low DE, et al.: A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprimsulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother. 2000; 44: 1089-92.
3. Goldstein FW: Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Eur J Clin Microbiol Infect Dis. 2000; 19: 112-7.
4. Bukharie HA, Saeed IM: Antimicrobial Resistance Among Pathogens Causing Acute Uncomplicated UTIs. Infect Med. 2001; 18: 358-62.
5. Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999; 281: 736-8.
6. Jones RN, Kugler KC, Pfaller MA, Winokur PL: Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis. 1999; 35: 55-63.
7. Jones RN: Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibility. MYSTIC Advisory Board. Meropenem Yearly Susceptibility Test Information Collection. J Antimicrob Chemother. 2000; 46 Suppl T2: 1-8.
8. Masterton RG: Surveillance studies: how can they help the management of infection? J Antimicrob Chemother. 2000; 46 Suppl T2:53-8.
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Wayne, Pa; 2000. NCCLS Document M100-S10.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Wayne, Pa; 2001. NCCLS Document M100-S11.
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Wayne, Pa; 2002. NCCLS Document M100-S12.
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Wayne, Pa; 2003. NCCLS Document M100-S13.
13. Altman DG: Practical Statistics for Medical Research. London, Chapman & Hall. 1991, pp. 611.
14. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD: Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000; 10: 509-15.
15. Hummers-Pradier E, Koch M, Ohse AM, Heizmann WR, Kochen MM: Antibiotic resistance of urinary pathogens in female general practice patients. Scand J Infect Dis. 2005; 37: 256-61.
16. Alos JI, Serrano MG, Gomez-Garces JL, Perianes J: Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect. 2005; 11: 199-203.
17. Kahlmeter G, Menday P: Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother. 2003; 52: 128-31.
18. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D: A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect. 2003; 46: 94-100.
19. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW: Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal. group. N Engl J Med. 2001; 345: 1007-13.